Defending medical oncology to assure quality care for cancer patients

December 13, 2013

Medical oncologists have a vital role to play in cancer care, particularly as treatments become ever more complex, a new position statement [1] from the European Society for Medical Oncology says.

Medical oncologists are specialist cancer physicians trained to provide treatment with drugs, spanning from the old one-fits-all chemotherapy to newer targeted agents or immunotherapies attacking the disease at its core.

ESMO's aim with the position statement, published today in the Annals of Oncology, is to guarantee to Europe's growing number of cancer patients access to optimal treatment, says Razvan Popescu, Chair of the ESMO National Representatives and Membership Committee, main sponsor of the paper.

"There are many complex decisions to be made around cancer treatment, and recent scientific advances are making the provision of optimal care even more challenging," said Popescu. "Only training prepares physicians to deal with this complexity."

Medical oncology as a specialty has existed since the 1960s. It was formally recognised in the European Union as an independent medical specialty and professional qualification only in March 2011 [2].

The new ESMO position paper takes the speciality a step further, by outlining formally for the first time the role of medical oncologists. Developed in consultation with medical oncologists and professional organisations across Europe, endorsed by all medical oncology societies in Europe, it represents a consensus view of the medical oncologist's place in the treatment of cancer.

"We hope that this position paper will be useful to individual countries in their discussions for the recognition of medical oncology as a specialty where it is not yet recognized and to defend the profession where possible challenges arise," Popescu said.

The ESMO statement establishes, among others, what the internationally recognised standard of education and training should be for a medical oncologist. "These standards will help ensure that patients receive the best possible care and that professionals achieve qualifications that will be recognised across Europe," said Popescu.

"By bringing attention to the role of medical oncology, ESMO hopes to improve the treatment of patients across Europe," said ESMO President Martine Piccart.

"Cancer is a complex disease, and quality cancer care should be provided by multidisciplinary teams of medical professionals, including radiation oncologists and surgeons," Piccart said.

"Medical oncologists are a core member of such teams, offering a patient-centred holistic approach to quality that aims to guide and support the patient through the entire 'cancer journey'," Piccart said.

Explore further: Better guidelines, coordination needed for prostate cancer specialists

More information: [1] Popescu RA, Schäfer R, Califano R et al. The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO). Ann Oncol 2013; 25: 9-15: annonc.oxfordjournals.org/cont … 25/1/9.full.pdf+html

[2] www.esmo.org/Policy/Recognitio … -of-Medical-Oncology

Related Stories

Better guidelines, coordination needed for prostate cancer specialists

December 9, 2013
With a deluge of promising new drug treatments for advanced prostate cancer on the market, a new model of care is needed that emphasizes collaboration between urologists and medical oncologists, according to UC Davis prostate ...

Radiation oncologists are discussing infertility risks with young cancer patients

March 8, 2012
More than 80 percent of radiation oncologists discuss the impact of cancer treatments on fertility with their patients of childbearing age, which can lead to improved quality of life for young cancer patients who are living ...

New approaches to testing cancer drugs needed

September 30, 2013
Research institutes, regulators and the pharmaceutical industry are urged to cooperate to develop new approaches to testing cancer drugs, in order to bring the revolution in personalised medicine to patients across Europe, ...

Round-the-clock A&E cancer doctors revolutionise treatment for patients

November 6, 2013
Having on-site cancer consultants in hospitals with Accident and Emergency (A&E) departments improves diagnosis and treatment of patients and reduces their hospital stay, according to data presented at the National Cancer ...

Oncologists improve quality of care for cancer patients

October 29, 2013
A pilot initiative conducted at Mount Sinai Hospital offers compelling evidence that establishing standardized criteria for calling a palliative care consultation improves the quality of care for patients hospitalized with ...

Oncologists report high career satisfaction, yet many suffer symptoms of burnout

June 2, 2013
Even though a majority of U.S. oncologists report satisfaction with their careers, many say they have experienced at least one symptom of burnout, a Mayo Clinic-led study has found. The study was released during the American ...

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.